Chicago Atlantic Real Estate Finance, Inc.

Chicago Atlantic Real Estate Finance, Inc. (REFI) Market Cap

Chicago Atlantic Real Estate Finance, Inc. has a market capitalization of .

No quote data available.

CEO: Anthony Robert Cappell

Sector: Real Estate

Industry: REIT - Mortgage

IPO Date: 2021-12-08

Website: https://investors.refi.reit

Chicago Atlantic Real Estate Finance, Inc. (REFI) - Company Information

Market Cap: -|Sector: Real Estate

Company Profile

Chicago Atlantic Real Estate Finance, Inc. operates as a commercial real estate finance company in the United States. It originates, structures, and invests in first mortgage loans and alternative structured financings secured by commercial real estate properties. The company offers senior loans to state-licensed operators and property owners in the cannabis industry. It has elected to be taxed as a real estate investment trust (REIT) and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was incorporated in 2021 and is based in Chicago, Illinois.

Analyst Sentiment

73%
Strong Buy

From 5 Active Polls

1Y Forecast: $17.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$14

Median

$17

High Bound

$20

Average

$17

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$17.00
▲ +50.71% Upside
Low Target
$14.00
24% Risk
Median Target
$17.00
51% Mid
High Target
$20.00
77% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CHICAGO ATLANTIC REAL ESTATE FINAN (REFI) — Investment Overview

🧩 Business Model Overview

Chicago Atlantic Real Estate Finance (“REFI”) operates as a real estate finance platform focused on originating and/or investing in mortgage and real-estate-related credit. The value chain is centered on (1) sourcing loan opportunities and structuring terms, (2) underwriting borrower and collateral quality, (3) holding and managing a portfolio through economic cycles, and (4) generating returns through interest income and credit performance, with risk mitigation supported by leverage management and hedging practices where applicable.

The core “stickiness” in this model is not customer switching costs in a consumer sense; it is portfolio-level retention of underwriting expertise and repeatable credit selection. Over time, superior deal structuring and credit discipline can translate into more resilient risk-adjusted earnings and improved access to capital markets—an important advantage for entities that finance assets using borrowed capital.

💰 Revenue Streams & Monetisation Model

REFI’s primary earnings power stems from spread between (a) the yield earned on mortgage and real-estate credit assets and (b) the cost of funding those assets. Secondary contributors can include loan-related fees (when applicable), servicing-related income (if the model includes such activities), and gains or losses tied to asset valuation and hedging effectiveness.

Key margin drivers typically include:

  • Net interest spread: loan yields versus borrowing costs.
  • Credit performance: delinquencies, loss severities, and recovery rates that determine how much yield converts into distributable income.
  • Financing efficiency: leverage level, term profile of funding, and ability to refinance without materially worsening economics.
  • Hedging discipline: effectiveness in reducing interest-rate and market-value volatility for eligible exposures.

🧠 Competitive Advantages & Market Positioning

The competitive set for real-estate finance and mortgage credit platforms typically includes other mortgage REITs and specialty real estate lenders that compete for similar loan types, funding structures, and risk-adjusted returns. Relevant peers/benchmarks include:

  • American Capital Agency (AGNC) — mortgage REIT focused largely on agency MBS exposure.
  • Annaly Capital Management (NLY) — agency mortgage REIT with a similar focus on rate-sensitive mortgage assets.
  • Arbor Realty Trust (ABR) — commercial real estate lender with a different credit mix but overlapping collateral and refinancing themes.

Compared with AGNC and NLY’s more agency-centric posture, REFI’s differentiator is its credit selection and exposure structure within real-estate finance, where outcomes depend more on underwriting and collateral-specific risk management than on purely agency-backed coupon stability. Versus ABR and other specialty lenders, REFI’s positioning is best evaluated by the consistency of its underwriting standards, the discipline embedded in its portfolio construction, and the stability of financing terms relative to peers.

Moat framework (hard-to-copy advantages):

  • Credit Culture (Credit Culture): durable underwriting standards, loss forecasting, and collateral management can be difficult for competitors to replicate quickly because the “learning” is embedded in historical portfolio outcomes and processes.
  • Cost of Capital (Cost Advantages): financing efficiency—reflected in leverage management, funding structure, and access to capital—can compound returns by widening the spread between asset yield and borrowing costs while controlling volatility.
  • Portfolio Construction Discipline (Intangible Processes): risk controls, underwriting frameworks, and covenants tailored to collateral realities help reduce tail risk, which is a structural advantage in credit cycles.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, REFI’s growth and return profile can be influenced by secular demand for real-estate financing and the market’s recurring need to refinance and redeploy capital. Key drivers include:

  • Refinancing cycle: amortizing loan books and periodic maturities create ongoing demand for replacement capital, especially where banks reduce capacity or adjust underwriting postures.
  • Capital markets dislocation support: periods of constrained securitization or limited balance-sheet availability can increase the value of lenders that can underwrite and fund responsibly.
  • Real-estate cash-flow resilience and asset turnover: property-level fundamentals (occupancy, rent growth/declines, expense inflation) influence loan performance and portfolio recycling opportunities.
  • Risk-based pricing and underwriting sophistication: disciplined structuring (term, amortization, collateral controls, and borrower covenants) can allow incremental origination without proportionate deterioration in credit outcomes.

⚠ Risk Factors to Monitor

  • Interest-rate and spread risk: the economics of mortgage/real-estate credit can be sensitive to funding costs, yield curves, and the relative attractiveness of competing capital sources.
  • Credit deterioration and liquidity stress: recessions, specific-asset impairment, or refinancing failures can raise loss rates and reduce recovery values.
  • Leverage and refinancing risk: reliance on borrowed capital can amplify volatility if funding markets tighten or if term availability shortens.
  • Hedging effectiveness risk: mismatches between hedges and underlying exposures can lead to volatility in earnings and equity.
  • Regulatory and tax-structure risk: REIT or similar structures impose distribution and compliance requirements that can constrain flexibility and affect realized outcomes.

📊 Valuation & Market View

Markets typically value real estate finance entities through metrics that emphasize balance sheet durability, earnings stability under leverage, and downside protection. Common valuation lenses include:

  • Price-to-book (and tangible book where used): highlights the market’s view of asset valuation, credit losses, and mark-to-market dynamics.
  • Dividend/distributable earnings quality: focus tends to be on how much distributable income is supported by cash flows versus non-cash valuation impacts.
  • Risk-adjusted return measures: the market often discounts earnings with higher probability of impairment, even when headline yields appear attractive.

Key drivers that typically move valuation include expected credit outcomes, funding stability, hedging performance, and the sustainability of net interest economics across rate and credit cycles.

🔍 Investment Takeaway

REFI’s investment case is primarily a credit-cycle and cost-of-capital story: returns hinge on underwriting discipline, loss control, and financing efficiency more than on transient market momentum. The durable advantage is best framed as credit culture plus process-driven portfolio construction, which can translate into more resilient risk-adjusted earnings through refinancing demand and market dislocations.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"REFI (most recent: 2026-03-31 Q1) reported Revenue of $15.16M and Net Income of $4.84M, with EPS of $0.23. YoY, revenue rose +16.3% (from $13.04M in 2025-03-31 Q1) while net income fell -51.8% (from $10.04M). QoQ, revenue declined -5.6% (vs. $16.08M in 2025-12-31 Q4) and net income declined -40.6% (from $8.15M). Profitability remains high on a gross-margin basis (gross margin ~88.7% in Q1 2026 vs. ~87.9% in Q4 2025), but the operating/bottom-line momentum is weakening, with net margin down to ~31.9% (from ~50.7% in Q4 2025). Cash flow quality is mixed: operating cash flow was $3.16M, roughly tracking net income for the quarter, and free cash flow was ~$3.16M. However, dividends are substantial relative to earnings (dividends paid ~$9.91M in Q1), implying a payout pressure regime and leaving free-cash coverage constrained. Balance sheet resilience is supported by very large cash levels (~$27.86B) and equity (~$303.4B). Total shareholder returns are pressured by weak market momentum: 1-year price change is -12.44% and no dividend/buyback contribution is provided to offset price depreciation. Valuation appears inexpensive on P/E (~0.012x) but is likely distorted by accounting/ratio artifacts; analyst targets are $17 consensus vs. $12.11 price."

Revenue Growth

Fair

YoY revenue increased +16.3% (Q1 2026 vs Q1 2025), but QoQ revenue fell -5.6% (vs Q4 2025), indicating decelerating sequential momentum.

Profitability

Caution

Gross margin improved slightly (~88.7% vs ~87.9%), but net margin contracted to ~31.9% from ~50.7% QoQ. Net income fell -51.8% YoY and -40.6% QoQ, with EPS down to $0.23.

Cash Flow Quality

Caution

Operating cash flow was $3.16M and free cash flow ~$3.16M in Q1 2026, broadly consistent with quarterly profitability. Dividend outflows (~$9.91M) are large versus operating cash generation, suggesting payout pressure.

Leverage & Balance Sheet

Good

Very strong cash position (~$27.86B) and large equity (~$303.4B). Total debt is comparatively small (~$49.4B short-term), and balance sheet strength appears resilient despite dividend outflows.

Shareholder Returns

Neutral

Price momentum is weak: 1y change -12.44%. Dividend yield is very high in the ratios (~41.5%), but the financials suggest payouts exceed earnings/cash generation in the quarter; buybacks are not evident.

Analyst Sentiment & Valuation

Neutral

Consensus target of ~$17 vs. $12.11 current implies upside, but the stock’s 1-year performance is negative and valuation ratios appear distorted (extremely low P/E).

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

REFI’s Q1 2026 results show stable distributable earnings but mixed credit signals: YTM dipped to 15.8% from 16.3%, while risk-rated 4+ rose to 10.7% (from 4.8%) and CECL increased ~$3.8M, driven mainly by LTV increases and a loan #36 downgrade. Offsetting this, nonaccrual improved sharply to 4.8% from 11.1% as loan #9 returned to accrual after three months of timely payments and sustained performance improvements following earlier workout actions. Regulatory remains the dominant catalyst. The DOJ’s April 23 announcement moving certain medical products to Schedule III is expected to remove 280E burdens and provide retrospective tax relief, strengthening operator cash flows and potentially accelerating valuation/credit normalization. Management highlighted a June 29–July 15 administrative hearing for further rescheduling. Through April 1–today, REFI deployed ~$15.8M new growth (including $13.1M to a new borrower) and collected ~$14.3M repayments, reinforcing portfolio resiliency amid Fed/macro volatility.

AI IconGrowth Catalysts

  • Federal medical rescheduling to Schedule III (announced April 23) expected to eliminate/relieve Section 280E burden and support operator cash flows, strengthening borrower credit profiles
  • Administrative hearing window for further rescheduling scheduled June 29 to July 15; potential adult-use expansion could broaden valuation and lending opportunity set
  • Ongoing portfolio workout momentum: loan #9 returned to accrual after three consecutive months of timely payments and sustained performance improvement

Business Development

  • New growth loan advances post-quarter: $13.1 million to a new borrower and $2.7 million to existing borrowers via delayed draws on credit facilities (advanced after April 1, 2026)
  • Loan origination activity: $16.2 million funded to new borrowers and $37.8 million to existing borrowers during Q1

AI IconFinancial Highlights

  • Portfolio principal ~$414 million across 25 portfolio companies; weighted average yield to maturity 15.8% vs 16.3% in Q4 2025
  • Risk migration: risk-rated 4+ increased to 10.7% from 4.8% at 12/31/2025; CECL reserves increased by ~$3.8 million (driven by LTV/loan #36 downgrade from 3 to 4)
  • Nonaccrual improved: 4.8% of portfolio nonaccrual vs 11.1% at 12/31/2025, primarily from restoring loan #9 to accrual
  • Net interest income $13.1 million, down $1.2 million (8%) from $14.2 million in Q4 2025; driven by Q4 recognition of $1.7 million of past-due unaccrued interest on loan #9
  • CECL reserve: ~$8.7 million; 2.1% of outstanding principal; reserve increased ~$3.8 million primarily from LTV increases in loans #4, #34, and #36; real estate coverage 1.2x on a weighted average basis
  • Distributable earnings per weighted average share: ~$0.47 basic and ~$0.46 fully diluted (Q1)
  • Leverage: 38% of book equity at 3/31/2026 vs 32% at 12/31/2025
  • Liquidity/deployments after quarter: advanced $15.8 million growth principal (to new and existing borrowers) and received $14.3 million repayments (including scheduled amortization $1.8 million and early prepayments $12.5 million; full repayment of loans #6 and #30)

AI IconCapital Funding

  • Senior secured revolver: $67.1 million outstanding at 3/31/2026; ~$59 million available as of call date
  • Unsecured term loan: $49.4 million outstanding at 3/31/2026
  • Total liquidity, net of estimated liabilities: ~$54 million
  • Dividend policy: payout ratio targeted at 90% to 100% of basic distributable earnings per share for 2026 tax year; fourth-quarter dividend paid in April: $0.47 per common share
  • Buybacks: none mentioned in transcript

AI IconStrategy & Ops

  • Rate-structure protection: floating rate loans benchmarked to prime and SOFR; with prime rate at 6.75%, 100% of prime loans at floors; ~4% of principal exposed to further rate declines across the total portfolio
  • No interest-rate caps on floating loans (structural advantage vs many mortgage REITs)
  • Workout approach highlighted: loan #9 turnaround via advance funding to allow accretive acquisitions; resolution through judicial foreclosure framework distinguished from constructive/resolution paths for other borrowers
  • Investor transparency initiative: released (at investors’ request) a breakdown between Canada real estate-backed vs non-real-estate loans

AI IconMarket Outlook

  • Federal rescheduling benefit timing: expected improvements predominantly through elimination of extra 280E tax burden and retrospective relief on legacy tax liabilities (impacting valuation multiples and credit profiles)
  • Regulatory timeline: administrative hearing scheduled June 29 to July 15; company remains measured and does not forecast outcome beyond hearing window
  • Pipeline visibility: cannabis opportunity pipeline stands at $482 million, including ~$133 million backed by real estate collateral
  • Pipeline refresh cadence: pipeline tends to refresh every 3 to 6 months; timing of closes within that window not forecastable

AI IconRisks & Headwinds

  • Net interest income pressure: $1.2 million (8%) quarterly decline due to reversal timing of past-due unaccrued interest recognition on loan #9
  • Credit provisioning risk: risk-rated 4+ increased to 10.7% (from 4.8%), with CECL reserve increase of ~$3.8 million tied to LTV increases in loans #4, #34, and #36 and loan #36 downgrade
  • Nonaccrual still present: 4.8% nonaccrual at 3/31/2026 despite improvement; ongoing conservative reserving
  • Macro/regulatory uncertainty: Fed pausing easing after 3 consecutive cuts and Middle East conflict volatility cited as continuing private credit market concerns
  • State/operator execution variability: rescheduling impact expected to differ by borrower based on medical market exposure; potential need for medical vs adult-use cost/tax parsing if adult-use rescheduling lags

Q&A: Analyst Interest

  • Loan #36 (Illinois, ~$27M) specifics and rationale: Management said Illinois faces retail consolidation and increasing cultivation competition, while loan #36 has strong real estate coverage and a vertically integrated operator. Reserving was framed as ordinary course evaluation with constructive borrower discussions and an expectation performance can improve collaboratively.
  • Schedule III implications for CECL and portfolio mix: Management stated reserves increased from a mix of specific and general components, reflecting 3/31 market/discount rates and LTV/cash-flow inputs, not subsequent rescheduling. They suggested CECL releases are possible in 2026 as market and operating fundamentals flow into CECL assumptions.
  • Medical vs adult-use classification complexity and underwriting adjustments: Management said most borrowers run adult-use and medical through shared dispensaries, but they do not publish the split. They hope in 2026 it becomes irrelevant as adult-use reschedules; otherwise borrowers may re-allocate costs for tax efficiency and regulators may redefine medical programs.

Sentiment: MIXED

Note: This summary was synthesized by AI from the REFI Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Chicago Atlantic Real Estate Finance, Inc. (REFI) Financial Profile